Literature DB >> 8180572

Risk of preneoplastic and neoplastic events in operated oral leukoplakias.

F Chiesa1, P Boracchi, N Tradati, N Rossi, L Costa, R Giardini, M Marazza, S Zurrida.   

Abstract

We retrospectively analysed 167 consecutive patients with oral leukoplakias operated on by CO2 laser resection in the Day Hospital of the Istituto Nazionale Tumori in Milan from January 1981 to December 1988, with post-operative histological examination negative for cancer. Within 5 years there were 69 patients with at least one unfavourable event. First unfavourable events were: 31 local relapses, 27 new leukoplakias, 5 oral carcinomas and 6 other neoplasms elsewhere. To identify possible prognostic factors we recorded age, sex and history of previous oral leukoplakias or head and neck cancers; also number, site, size and type of lesion; as well as tobacco and alcohol consumption and oral hygiene. The Cox regression model was employed to compare disease-free survival between different patient groups, both by univariate and multivariate analysis. From this analysis it emerges that age of operated patients and size of resected lesion are significantly predictive for development of relapses, new leukoplakias and carcinomas.

Entities:  

Mesh:

Year:  1993        PMID: 8180572     DOI: 10.1016/0964-1955(93)90006-z

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  12 in total

1.  CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation.

Authors:  Waseem Jerjes; Tahwinder Upile; Zaid Hamdoon; Mohammed Al-Khawalde; Mira Morcos; Charles Alexander Mosse; Colin Hopper
Journal:  Lasers Med Sci       Date:  2011-04-15       Impact factor: 3.161

2.  Minor Salivary Gland Changes in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma - A Histopathological Study.

Authors:  Sunil Paramel Mohan; Ravi Teja Chitturi; Yoithapprabhunath Thukanayakanpalayam Ragunathan; Suman Jhansi Lakshmi; Jaisanghar Nallusamy; Isaac Joseph
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

4.  Designing a Mucoadhesive ChemoPatch to Ablate Oral Dysplasia for Cancer Prevention.

Authors:  Xiaoqin Liu; Qian Li; Yang Wang; Madeleine Crawford; Parnit K Bhupal; Xiuqing Gao; Huan Xie; Dong Liang; Yi-Shing L Cheng; Xiaohua Liu; Robert Y L Tsai
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

Review 5.  Oral premalignancy: the roles of early detection and chemoprevention.

Authors:  Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny
Journal:  Otolaryngol Clin North Am       Date:  2013-05-25       Impact factor: 3.346

6.  Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Han Yang; Cheng-Ming Luo; Pei-Wen Wu
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

Review 7.  CO2 lasers in the management of potentially malignant and malignant oral disorders.

Authors:  Waseem Jerjes; Zaid Hamdoon; Colin Hopper
Journal:  Head Neck Oncol       Date:  2012-04-30

8.  Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study.

Authors:  L Monteiro; C Barbieri; S Warnakulasuriya; M Martins; F Salazar; J-J Pacheco; P Vescovi; M Meleti
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-09-01

9.  Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Cheng Hwang; Tai-An Chen
Journal:  Head Neck       Date:  2020-01-13       Impact factor: 3.147

Review 10.  Leukoplakia and Immunology: New Chemoprevention Landscapes?

Authors:  Roberto Grigolato; Maria Eleonora Bizzoca; Luca Calabrese; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.